Mesh Bio

About:

Mesh Bio is a digital health startup that is transforming chronic disease management through predictive analytics.

Top Investors: East Ventures, Seed Capital, Elev8.VC, Seeds Capital, Tael Partners

Description:

Mesh Bio is a digital health startup that is transforming chronic disease management through predictive analytics. Mesh Bio works with healthcare providers and stakeholders to provide innovative solutions that transform health screening and disease management. They translate clinical data and numbers into actionable insights that help patients better manage their health, lifestyle and disease risks.

Total Funding Amount:

$5.3M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Bukit Merah, Central Region, Singapore

Founded Date:

2018-01-01

Contact Email:

contactus(AT)meshbio.com

Founders:

Andrew Wu, Arsen Batagov, Melvin Heng

Number of Employees:

11-50

Last Funding Date:

2023-10-12

IPO Status:

Private

Industries: